Published On: January 22nd, 2024


Published On: January 22nd, 2024


Arbor Research Collaborative for Health (Arbor Research) recently welcomed Dr. Ping Yu, as Chief Growth Officer. In his new role at Arbor Research, Dr. Yu will lead the Strategic Growth Team (SGT) to further expand Arbor Research’s growth initiatives.

Dr. Yu brings a wealth of experience in health data, analytics, research, and evaluation, with a distinguished career spanning close to 40 years in the contract research arena. Previously creating and overseeing Booz Allen’s social science research practice as its Principal, Dr. Yu played a pivotal role in driving strategies to expand capabilities across health, especially in data science, analytics, research, and evaluation. Dr. Yu has designed and executed evaluations for healthcare quality improvement programs for the Centers for Medicare and Medicaid Services (CMS) and has developed innovative methodology and advanced analytics to help Federal Government agencies and other clients drive their mission and assess their programs’ return on investment. His leadership extends to multiyear, multimillion projects for clients such as CMS, Centers for Disease Control and Prevention, and Substance Abuse and Mental Health Services Administration (SAMHSA). Notably, he led the CMS Independence Evaluation Contract (IEC) and conducted significant studies for SAMHSA in the behavioral health domain.

Before his tenure at Booz Allen, Dr. Yu directed the Substance Abuse Research and Evaluation Group at Battelle Memorial Institute, where he also collaborated with the Chinese Academy of Sciences in the Joint Center for International Research. His diverse background includes work in support of the pharmaceutical industry with technical expertise in surveys, statistics and demography, business development, pricing, and project management.

Dr. Yu holds a Ph.D. in Demography from Cornell University, an M.A. from Georgetown University, and a B.A. in American Studies from Canton University of Trade and Foreign Languages.

Expressing his enthusiasm, Dr. Yu stated, “I am excited to contribute to the growth and success of Arbor Research. Returning to a small business environment feels like coming full circle in my career. I look forward to collaborating with every staff at every level and achieving Arbor’s ambitious 5-year strategic plan.”

“Dr. Yu’s extensive experience and strategic vision will play a pivotal role in advancing Arbor’s mission and fostering our continued success in the research and evaluation sector,” says President and CEO of Arbor Research, Dr. Christopher Spera. “Ping’s charge will continue the strong success of the SGT and continue to build out the growth function within Arbor.”

Related Posts

  • Arbor Research Collaborative for Health (Arbor Research), a leading provider of innovative solutions in healthcare research, is pleased to announce its participation in the upcoming World Congress of Nephrology (WCN) 2024, scheduled to take place from April 13th to 16th, 2024. The WCN 2024 conference, organized by the International Society of Nephrology (ISN), is a […]

  • Arbor Research is pleased to announce the appointment of Dr. Steve Hines, PhD as a Senior Research Scientist focusing on health services research and strategic partnerships. Dr. Hines brings a wealth of experience and expertise, having most recently led learning community activities for the AHRQ-funded TAKEheart project while his work updating AHRQ’s TeamSTEPPS training curriculum […]

  • Advancing the scientific understanding of kidney disease to inform healthcare practice and policy is at the core of Arbor Research’s history.  Founded in 1996 in Ann Arbor, Michigan by three leaders in chronic kidney disease care and research, we were originally named the University Renal Research and Education Association (URREA). Arbor Research’s first project was […]

  • The Dialysis Outcomes and Practice Patterns Study (DOPPS) Program at Arbor Research Collaborative for Health is pleased to share their recent publication recognized as one of the most- downloaded articles at Kidney International Reports in the past few weeks titled “Alkaline Phosphatase and Parathyroid Hormone Levels: International Variation and Associations With Clinical Outcomes in the […]